• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

推注生长抑素预防内镜下胰胆管造影术后胰腺炎的效果:一项随机研究的结果

Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study.

作者信息

Bordas J M, Toledo-Pimentel V, Llach J, Elena M, Mondelo F, Ginès A, Terés J

机构信息

Gastrointestinal Endoscopy Section, Hospital Clinic I Provincial, University of Barcelona, Spain.

出版信息

Gastrointest Endosc. 1998 Mar;47(3):230-4. doi: 10.1016/s0016-5107(98)70318-9.

DOI:10.1016/s0016-5107(98)70318-9
PMID:9540874
Abstract

BACKGROUND

Pancreatitis is a potential problem in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP). Natural somatostatin reduces pancreatic secretion and has been administered in acute pancreatitis. To establish whether an injection of a single "bolus" of natural somatostatin is useful in preventing pancreatic reactions after endoscopic pancreatography, a randomized study was carried out in 160 patients undergoing pancreatography, associated or not, with endoscopic sphincterotomy.

METHODS

Pancreatitis was considered to be present when there was the simultaneous appearance of serum amylase above 600 IU/mL and serum lipase above 200 IU, upper abdominal pain with tenderness, nausea and/or vomiting, and associated ileus, not completely resolved within 18 hours after the procedure and prolonging hospital stay.

RESULTS

The incidence of pancreatitis (10% vs. 2.5%, p < 0.05) was higher in the placebo group than in the somatostatin-treated group. The difference in frequency of pancreatitis was statistically significant (18% vs 0%, p < 0.05) in the ERCP plus sphincterotomy subgroup but not significant (6% versus 4%) in the ERCP subgroup.

CONCLUSIONS

These results suggest that the administration of a single bolus injection of natural somatostatin just before cannulation of the papilla may be useful in preventing pancreatitis. This procedure is useful in patients undergoing sphincterotomy. Further studies should be performed to determine whether this drug is useful in cases in which cannulation of the papilla is difficult or when therapeutic procedures require prolonged and/or aggressive manipulation of the papilla.

摘要

背景

胰腺炎是接受内镜逆行胰胆管造影术(ERCP)患者的一个潜在问题。天然生长抑素可减少胰腺分泌,已用于治疗急性胰腺炎。为确定在内镜胰腺造影术前注射单次“大剂量”天然生长抑素是否有助于预防胰腺不良反应,对160例接受胰腺造影术(无论是否联合内镜括约肌切开术)的患者进行了一项随机研究。

方法

当血清淀粉酶高于600 IU/mL且血清脂肪酶高于200 IU,同时出现上腹部疼痛伴压痛、恶心和/或呕吐以及相关肠梗阻,且在术后18小时内未完全缓解并延长住院时间时,即认为发生了胰腺炎。

结果

安慰剂组胰腺炎的发生率(10%对2.5%,p<0.05)高于生长抑素治疗组。在ERCP加括约肌切开术亚组中,胰腺炎发生频率的差异具有统计学意义(18%对0%,p<0.05),但在ERCP亚组中差异无统计学意义(6%对4%)。

结论

这些结果表明,在乳头插管前单次注射天然生长抑素可能有助于预防胰腺炎。该方法对接受括约肌切开术的患者有用。应进一步开展研究,以确定该药物在乳头插管困难或治疗操作需要对乳头进行长时间和/或积极操作的情况下是否有用。

相似文献

1
Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study.推注生长抑素预防内镜下胰胆管造影术后胰腺炎的效果:一项随机研究的结果
Gastrointest Endosc. 1998 Mar;47(3):230-4. doi: 10.1016/s0016-5107(98)70318-9.
2
Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy.在内镜逆行胰胆管造影术和内镜括约肌切开术患者中通过推注生长抑素预防胰腺反应。
Horm Res. 1988;29(2-3):106-8. doi: 10.1159/000180981.
3
Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.诊断性胆胰管造影术后静脉推注生长抑素可降低与治疗性内镜逆行胆胰管造影术相关的胰腺炎发生率:一项随机对照试验。
Gut. 2003 Dec;52(12):1768-73. doi: 10.1136/gut.52.12.1768.
4
Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial.生长抑素能预防内镜逆行胰胆管造影术后胰腺炎吗?一项随机对照试验的结果。
J Gastroenterol Hepatol. 2004 Mar;19(3):278-82. doi: 10.1111/j.1440-1746.2003.03297.x.
5
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.对于有ERCP术后胰腺炎高风险的患者,在ERCP术前给予加贝酯或生长抑素:一项多中心、安慰剂对照、随机临床试验。
Gastrointest Endosc. 2002 Oct;56(4):488-95. doi: 10.1067/mge.2002.128130.
6
The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.生长抑素对治疗后内镜逆行胰胆管造影术所致胰腺炎的预防作用:一项随机、多中心对照试验。
Pancreas. 2008 Nov;37(4):445-8. doi: 10.1097/MPA.0b013e3181733721.
7
Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.内镜逆行胰胆管造影术(ERCP)相关胰腺炎的预防:生长抑素和甲磺酸加贝酯的随机对照试验
Clin Gastroenterol Hepatol. 2004 Aug;2(8):713-8. doi: 10.1016/s1542-3565(04)00295-2.
8
Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.生长抑素预防内镜逆行胰胆管造影术后胰腺炎:一项随机双盲试验。
Endoscopy. 2014 Oct;46(10):851-6. doi: 10.1055/s-0034-1377306. Epub 2014 Jun 30.
9
Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.生长抑素对内镜逆行胰胆管造影术后胰腺炎的预防作用:一项随机对照试验。
Gastrointest Endosc. 1999 May;49(5):593-8. doi: 10.1016/s0016-5107(99)70387-1.
10
Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.萘普生栓降低内镜逆行胰胆管造影术后胰腺炎的发生率和严重程度:随机对照试验。
World J Gastroenterol. 2016 Jun 7;22(21):5114-21. doi: 10.3748/wjg.v22.i21.5114.

引用本文的文献

1
Role of Somatostatin in Preventing Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: An Update Meta-analysis.生长抑素在预防内镜逆行胰胆管造影术(ERCP)后胰腺炎中的作用:一项更新的荟萃分析。
Front Pharmacol. 2016 Dec 15;7:489. doi: 10.3389/fphar.2016.00489. eCollection 2016.
2
Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis.生长抑素预防内镜逆行胰胆管造影术后胰腺炎的效果:一项更新的荟萃分析
Saudi J Gastroenterol. 2015 Nov-Dec;21(6):372-8. doi: 10.4103/1319-3767.167187.
3
Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients.
在内镜逆行胰胆管造影术(ERCP)前给予生长抑素,对于降低高危患者ERCP术后胰腺炎的风险是有效的。
Exp Ther Med. 2014 Aug;8(2):509-514. doi: 10.3892/etm.2014.1733. Epub 2014 May 26.
4
Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review.内镜逆行胰胆管造影术相关胰腺炎:一项15年的回顾。
World J Gastrointest Endosc. 2010 May 16;2(5):165-78. doi: 10.4253/wjge.v2.i5.165.
5
Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis.荟萃分析:生长抑素或其长效类似物奥曲肽预防 ERCP 术后胰腺炎。
J Gastroenterol. 2010 Aug;45(8):885-95. doi: 10.1007/s00535-010-0234-4. Epub 2010 Apr 7.
6
Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure.内镜逆行胰胆管造影术后胰腺炎与术后血清淀粉酶水平变化之间的关系。
World J Gastroenterol. 2007 Jul 28;13(28):3855-60. doi: 10.3748/wjg.v13.i28.3855.
7
Mild ERCP-induced and non-ERCP-related acute pancreatitis: two distinct clinical entities?轻度内镜逆行胰胆管造影术(ERCP)诱发的和非ERCP相关的急性胰腺炎:两种不同的临床实体?
J Gastroenterol. 2007 Feb;42(2):146-51. doi: 10.1007/s00535-006-1979-7. Epub 2007 Mar 12.
8
The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis.神经肽激素生长抑素对曼氏血吸虫所致肝纤维化的治疗作用。
BMC Infect Dis. 2005 Jun 10;5:45. doi: 10.1186/1471-2334-5-45.
9
Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.诊断性胆胰管造影术后静脉推注生长抑素可降低与治疗性内镜逆行胆胰管造影术相关的胰腺炎发生率:一项随机对照试验。
Gut. 2003 Dec;52(12):1768-73. doi: 10.1136/gut.52.12.1768.
10
Effect of somatostatin on the sphincter of Oddi in patients with acute non-biliary pancreatitis.生长抑素对急性非胆源性胰腺炎患者Oddi括约肌的影响。
Gut. 2001 Dec;49(6):843-6. doi: 10.1136/gut.49.6.843.